CLINICAL EXPERIENCES WITH THALIDOMIDE IN PATIENTS WITH CANCER.
D000568:Amenorrhea; D000970:Antineoplastic Agents; D003872:Dermatitis; D004358:Drug Therapy; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms; D008175:Lung Neoplasms; D009325:Nausea; D009362:Neoplasm Metastasis; D009365:Neoplasm Regression, Spontaneous; D009392:Nephrectomy; D009443:Neuritis; D013792:Thalidomide; D013924:Thrombophlebitis; D014116:Toxicology; D014839:Vomiting
D000970:Antineoplastic Agents; D013792:Thalidomide
AMENORRHEA; ANTINEOPLASTIC AGENTS; DERMATITIS; DRUG THERAPY; KIDNEY NEOPLASMS; LUNG NEOPLASMS; NAUSEA; NEOPLASM METASTASIS; NEOPLASM REGRESSION, SPONTANEOUS; NEPHRECTOMY; POLYNEURITIS; THALIDOMIDE; THROMBOPHLEBITIS; TOXICOLOGIC REPORT; VOMITING